Abstract:Applications of synthetic biology spanning human health, industrial bioproduction, and ecosystem monitoring often require small molecule sensing capabilities, typically in the form of genetically encoded small molecule biosensors. Critical to the deployment of greater numbers of these systems are methods that support the rapid development of such biosensors against a broad range of small molecule targets. Here, we use a previously developed method for selection of RNA biosensors against unmodified small molecules (DRIVER) to perform a selection against a densely multiplexed mixture of small molecules, representative of those employed in high-throughput drug screening. Using a mixture of 5,120 target compounds randomly sampled from a large diversity drug screening library, we performed a 95-round selection and then analyzed the enriched RNA biosensor library using next generation sequencing (NGS). From our analysis, we identified RNA biosensors with at least 2-fold change in signal in the presence of at least 217 distinct target compounds with sensitivities down to 25 nM. Although many of these biosensors respond to multiple targets, clustering analysis indicated at least 150 different small-molecule sensing patterns. We also built a classifier that was able to predict whether the biosensors would respond to a new compound with an average precision of 0.82. Since the target compound library was designed to be representative of larger diversity compound libraries, we expect that the described approach can be used with similar compound libraries to identify aptamers against other small molecules with a similar success rate. The new RNA biosensors (or their component aptamers) described in this work can be further optimized and used in applications such as biosensing, gene control, or enzyme evolution. In addition, the data presented here provide an expanded compendium of new RNA aptamers compared to the 82 small molecule RNA aptamers published in the literature, allowing further bioinformatic analyses of the general classes of small molecules for which RNA aptamers can be found.

NMR and SPR Fragment-Based Screening Can Produce Novel High Affinity Small Molecule Hits Against Structured RNAs

Targeting RNA with Small Molecules: Identification of Selective, RNA-Binding Small Molecules Occupying Drug-Like Chemical Space

Targeting RNA with Small Molecules using State-of-the-Art Methods Provides Highly Predictive Affinities of Riboswitch Inhibitors

Interrogating RNA-Small Molecule Interactions with Structure Probing and Artificial Intelligence-Augmented Molecular Simulations

Targeting RNA structures with small molecules

Physicochemical Principles Driving Small Molecule Binding to RNA

Small molecule approaches to targeting RNA

RNA-Binding Small Molecules in Drug Discovery and Delivery: An Overview from Fundamentals

Recognizing the power of machine learning and other computational methods to accelerate progress in small molecule targeting of RNA

Tertiary RNA Folding-Targeted Drug Screening Strategy Using a Protein Nanopore

Docking-based Virtual Screening for the Discovery of RNA-targeting Molecules: Identification of Selective Riboswitch Binding Ligands

Targeting RNA with small molecules: lessons learned from Xist RNA

Large-scale analysis of small molecule-RNA interactions using multiplexed RNA structure libraries

An enhanced biophysical screening strategy to investigate the affinity of ASOs for their target RNA

RNA-Small-Molecule Interaction: Challenging the "Undruggable" Tag

Targeting RNA with small molecules, from RNA structures to precision medicines: IUPHAR review: 40

RNAmigos2: Fast and accurate structure-based RNA virtual screening with semi-supervised graph learning and large-scale docking data

Highly multiplexed selection of RNA aptamers against a small molecule library

Advances in RNA therapeutics for modulation of 'undruggable' targets

AnnapuRNA: A scoring function for predicting RNA-small molecule binding poses